Using Stable Isotopes to Quantify Nitrogen Fates in Container Plants

Currently, in the agriculture field, it is not yet known the accurate amount of Nitrogen in fertilizer that plants take up. This statistic, known as the Nitrogen Use Efficiency is currently known to be within the 30-50% range (Lea-Cox and Ross, 2001). This is very important figure to know and it is a figure that can be improved, and therefore much time, energy, and resources can be saved. This research project will use concepts involving stable isotopes to examine red maple plant material and the soilless media that the plants were grown in. Three different isotope-labelled fertilizer treatments will be used to determine the amount of Nitrogen taken up in the plant, in the runoff water, and released to the atmosphere. Plant and media samples will be analyzed using a mass spectrometer and an accurate account of Nitrogen can then be made. The data show that the Nitrogen taken up by the plant mostly contributes to the growth of new plant material, although there are significant amounts of 15N in the old stem and old leaf samples. The conclusions that can be drawn are that Nitrogen that is processed into fertilizer is ultimately being wasted. Nitrogen is being leached into the ground water, immobilized by bacteria into organic Nitrogen, bound to the soil and media, and converted into NOx and N2; more research can be done, especially into the volatilization of the Nitrogen from fertilizers

The role of intra- and interdialytic sodium balance and restriction in dialysis therapies

The relationship between sodium, blood pressure and extracellular volume could not be more pronounced or complex than in a dialysis patient. We review the patients' sources of sodium exposure in the form of dietary salt intake, medication administration, and the dialysis treatment itself. In addition, the roles dialysis modalities, hemodialysis types, and dialysis fluid sodium concentration have on blood pressure, intradialytic symptoms, and interdialytic weight gain affect patient outcomes are discussed. We review whether sodium restriction (reduced salt intake), alteration in dialysis fluid sodium concentration and the different dialysis types have any impact on blood pressure, intradialytic symptoms, and interdialytic weight gain

Using herbs medically without knowing their composition: are we playing Russian roulette?

Herbal medicine, a form of complementary and alternative medicine (CAM), is used throughout the world, in both developing and developed countries. The ingredients in herbal medicines are not standardized by any regulatory agency. Variability exists in the ingredients as well as in their concentrations. Plant products may become contaminated with bacteria and fungi during storage. Therefore, harm can occur to the kidney, liver, and blood components after ingestion. We encourage scientific studies to identify the active ingredients in herbs and to standardize their concentrations in all herbal preparations. Rigorous studies need to be performed in order to understand the effect of herbal ingredients on different organ systems as well as these substances' interaction with other medications

Using herbs medically without knowing their composition: are we playing Russian roulette?

Herbal medicine, a form of complementary and alternative medicine (CAM), is used throughout the world, in both developing and developed countries. The ingredients in herbal medicines are not standardized by any regulatory agency. Variability exists in the ingredients as well as in their concentrations. Plant products may become contaminated with bacteria and fungi during storage. Therefore, harm can occur to the kidney, liver, and blood components after ingestion. We encourage scientific studies to identify the active ingredients in herbs and to standardize their concentrations in all herbal preparations. Rigorous studies need to be performed in order to understand the effect of herbal ingredients on different organ systems as well as these substances\u27 interaction with other medications

Haemodialysis-induced hypoglycaemia and glycaemic disarrays (vol 11, pg 302, 2015)

In patients with diabetes receiving chronic haemodialysis, both very high and low glucose levels are associated with poor outcomes, including mortality. Conditions that are associated with an increased risk of hypoglycaemia in these patients include decreased gluconeogenesis in the remnant kidneys, deranged metabolic pathways, inadequate nutrition, decreased insulin clearance, glucose loss to the dialysate and diffusion of glucose into erythrocytes during haemodialysis. Haemodialysis-induced hypoglycaemia is common during treatments with glucose-free dialysate, which engenders a catabolic status similar to fasting; this state can also occur with 5.55 mmol/l glucose-containing dialysate. Haemodialysis-induced hypoglycaemia occurs more frequently in patients with diabetes than in those without. Insulin therapy and oral hypoglycaemic agents should, therefore, be used with caution in patients on dialysis. Several hours after completion of haemodialysis treatment a paradoxical rebound hyperglycaemia may occur via a similar mechanism as the Somogyi effect, together with insulin resistance. Appropriate glycaemic control tailored for patients on haemodialysis is needed to avoid haemodialysis-induced hypoglycaemia and other glycaemic disarrays. In this Review we summarize the pathophysiology and current management of glycaemic disarrays in patients on haemodialysis